{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:25:49Z","timestamp":1794561949241,"version":"4.9.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,8]],"date-time":"2027-05-08T00:00:00Z","timestamp":1809734400000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA HD009024"],"award-info":[{"award-number":["ZIA HD009024"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018101","name":"McKenna Claire Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymgme.2026.110138","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:49:50Z","timestamp":1777996190000},"page":"110138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and biochemical footprints of inherited metabolic disorders: XIX. Hypoglycemia"],"prefix":"10.1016","volume":"148","author":[{"given":"Alessandro","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry G.J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110138_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2019.03.007","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. I. Movement disorders","volume":"127","author":"Ferreira","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109084","article-title":"Clinical and biochemical footprints of inherited metabolic diseases: Ia. Movement disorders, updated","volume":"145","author":"Peacock","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2019.04.002","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases","volume":"127","author":"Ferreira","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2020.02.007","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. III. Psychiatric presentations","volume":"130","author":"Horvath","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2020.12.290","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease","volume":"132","author":"Ferreira","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ymgme.2021.03.008","article-title":"Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes","volume":"137","author":"Horvath","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2021.07.005","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses","volume":"132","author":"Ferreira","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ymgme.2022.02.002","article-title":"Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes","volume":"135","author":"Garanto","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2022.03.011","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias","volume":"136","author":"Jerves","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2022.09.005","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. IX. Metabolic ear disease","volume":"137","author":"Bakhos","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2022.09.004","article-title":"Clinical and biochemical footprints of inherited metabolic disorders: X. Metabolic myopathies","volume":"137","author":"Angelini","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107528","article-title":"Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms","volume":"138","author":"Salazar","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107582","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects","volume":"139","author":"de Boer","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107655","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations","volume":"140","author":"Rossi","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107683","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases","volume":"140","author":"Schumann","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107690","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. XV. Epilepsies","volume":"140","author":"Latzer","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107735","article-title":"Clinical and biochemical footprints of inherited metabolic disease. XVI. Hematological abnormalities","volume":"140","author":"Dunlea","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0090","article-title":"Clinical and biochemical footprints of inherited metabolic diseases: XVII. Dysmorphisms","volume":"144","author":"Greene","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41436-018-0022-8","article-title":"A proposed nosology of inborn errors of metabolism","volume":"21","author":"Ferreira","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jimd.12348","article-title":"An international classification of inherited metabolic disorders (ICIMD)","volume":"44","author":"Ferreira","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110138_bb0105","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/glia.20440","article-title":"Hypoglycemia, brain energetics, and hypoglycemic neuronal death","volume":"55","author":"Suh","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2026.110138_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.6065\/apem.2015.20.4.179","article-title":"Endocrine and metabolic emergencies in children: hypocalcemia, hypoglycemia, adrenal insufficiency, and metabolic acidosis including diabetic ketoacidosis","volume":"20","author":"Kim","year":"2015","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0115","series-title":"Physician\u2019s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases","author":"Blau","year":"2022"},{"key":"10.1016\/j.ymgme.2026.110138_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/gim.2017.108","article-title":"Knowledge base and mini-expert platform for the diagnosis of inborn errors of metabolism","volume":"20","author":"Lee","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110138_bb0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","article-title":"A general introduction to the biochemistry of mitochondrial fatty acid \u03b2-oxidation","volume":"33","author":"Houten","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110138_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1464-5491.2009.02894.x","article-title":"Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications","volume":"27","author":"Gerich","year":"2010","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0140","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.90563.2008","article-title":"Four grams of glucose","volume":"296","author":"Wasserman","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1 Pt 1","key":"10.1016\/j.ymgme.2026.110138_bb0145","first-page":"E67","article-title":"Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction","volume":"260","author":"Mitrakou","year":"1991","journal-title":"Am. J. Phys."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110138_bb0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI112884","article-title":"Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms","volume":"79","author":"Schwartz","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.110138_bb0155","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/archdischild-2013-305718","article-title":"Endogenous glucose production from infancy to adulthood: a non-linear regression model","volume":"99","author":"Huidekoper","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2026.110138_bb0160","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2337\/diab.38.4.477","article-title":"Increased basal glucose production and utilization in children with recent obesity versus adults with long-term obesity","volume":"38","author":"Bougneres","year":"1989","journal-title":"Diabetes"},{"issue":"2\u20133","key":"10.1016\/j.ymgme.2026.110138_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","article-title":"Molecular pathophysiology of hepatic glucose production","volume":"46","author":"Sharabi","year":"2015","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0175","article-title":"Unraveling the regulation of hepatic gluconeogenesis","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymgme.2026.110138_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1190473","article-title":"Abnormal glucose homeostasis and fasting intolerance in patients with congenital porto-systemic shunts","volume":"14","author":"van Albada","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymgme.2026.110138_bb0185","first-page":"25","article-title":"Pyruvate carboxylase deficiency: an underestimated cause of lactic acidosis","volume":"2","author":"Habarou","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110138_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.11.020","article-title":"Natural history of TANGO2 deficiency disorder: baseline assessment of 73 patients","volume":"25","author":"Miyake","year":"2023","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0195","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/gim.2015.201","article-title":"Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis","volume":"18","author":"Diez-Fernandez","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0026-0495(82)90024-5","article-title":"Differences in circulating gluconeogenic substrates during short-term fasting in men, women, and children","volume":"31","author":"Haymond","year":"1982","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2026.110138_bb0205","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/diab.26.11.1016","article-title":"Measurement of \"true\" glucose production rates in infancy and childhood with 6,6-dideuteroglucose","volume":"26","author":"Bier","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2026.110138_bb0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.siny.2005.04.001","article-title":"Metabolic adaptation at birth","volume":"10","author":"Ward Platt","year":"2005","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.ymgme.2026.110138_bb0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000487222","article-title":"Newborn plasma glucose concentration nadirs by gestational-age group","volume":"113","author":"Kaiser","year":"2018","journal-title":"Neonatology"},{"key":"10.1016\/j.ymgme.2026.110138_bb0220","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1542\/peds.105.5.1141","article-title":"Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds","volume":"105","author":"Cornblath","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.110138_bb0225","doi-asserted-by":"crossref","DOI":"10.1177\/1179556517748913","article-title":"Hypoglycemia: when to treat?","volume":"11","author":"Kallem","year":"2017","journal-title":"Clin. Med. Insights Pediatr."},{"key":"10.1016\/j.ymgme.2026.110138_bb0230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpeds.2015.03.057","article-title":"Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children","volume":"167","author":"Thornton","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110138_bb0235","first-page":"463","article-title":"Glucose counterregulatory responses to hypoglycemia","volume":"9","author":"Sprague","year":"2011","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2026.110138_bb0240","series-title":"Inborn Metabolic Diseases","author":"Saudubray","year":"2022"},{"key":"10.1016\/j.ymgme.2026.110138_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1013874","article-title":"Syndromic forms of congenital hyperinsulinism","volume":"14","author":"Zenker","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110138_bb0250","first-page":"1","article-title":"Hypoglycemia in children referred to a tertiary care pediatric endocrine clinic: age-dependent etiological variations","volume":"98","author":"Gil Margolis","year":"2025","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110138_bb0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/dmcn.12574","article-title":"Seizures and epilepsy in hypoglycaemia caused by inborn errors of metabolism","volume":"57","author":"Gataullina","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2026.110138_bb0260","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.1210\/clinem\/dgae072","article-title":"Approach to the patient: investigation of pediatric hypoglycemia in the emergency department-a practical algorithm","volume":"109","author":"Thornton","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110138_bb0265","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1515\/jpem-2022-0589","article-title":"Fasting ketone levels vary by age: implications for differentiating physiologic from pathologic ketotic hypoglycemia","volume":"36","author":"Parmar","year":"2023","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110138_bb0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02072043","article-title":"The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states","volume":"150","author":"Bonnefont","year":"1990","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110138_bb0275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000531766","article-title":"International guidelines for the diagnosis and management of hyperinsulinism","volume":"97","author":"De Leon","year":"2024","journal-title":"Horm. Res. Paediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110138_bb0280","doi-asserted-by":"crossref","first-page":"e3612","DOI":"10.1210\/clinem\/dgac411","article-title":"A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: toward glycemic targets","volume":"107","author":"Rossi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110138_bb0285","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1177\/19322968241255842","article-title":"Continuous glucose monitoring-derived glycemic phenotyping of childhood hypoglycemia due to hyperinsulinism: a year-long prospective nationwide observational study","volume":"19","author":"Worth","year":"2025","journal-title":"J. Diabetes Sci. Technol."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110138_bb0290","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000506230","article-title":"Continuous glucose monitoring systems: are they useful for evaluating glycemic control in children with hyperinsulinism?","volume":"92","author":"Rayannavar","year":"2019","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ymgme.2026.110138_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1116864","article-title":"Continuous glucose monitoring for children with hypoglycaemia: evidence in 2023","volume":"14","author":"Worth","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110138_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70040","article-title":"State of the art and consensus statements by healthcare providers, patients, and caregivers on continuous glucose monitoring in liver glycogen storage diseases","volume":"48","author":"Derks","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110138_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.858832","article-title":"Dynamic methods for childhood hypoglycemia phenotyping: a narrative review","volume":"13","author":"Rossi","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110138_bb0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns8020031","article-title":"Towards achieving equity and innovation in newborn screening across Europe","volume":"8","author":"Sikonja","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110138_bb0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000443874","article-title":"Inborn errors of metabolism that cause sudden infant death: a systematic review with implications for population neonatal screening programmes","volume":"109","author":"van Rijt","year":"2016","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110138_bb0320","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13023-018-0875-6","article-title":"Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)\/long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency","volume":"13","author":"Lotz-Havla","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110138_bb0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/ijns7020032","article-title":"Glutaric aciduria type I missed by newborn screening: report of four cases from three families","volume":"7","author":"Spenger","year":"2021","journal-title":"Int. J. Neonatal Screen."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110138_bb0330","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jimd.12372","article-title":"The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein","volume":"44","author":"Gr\u00fcnert","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110138_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.684011","article-title":"An overview of hypoglycemia in children including a comprehensive practical diagnostic flowchart for clinical use","volume":"12","author":"Casertano","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymgme.2026.110138_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.826167","article-title":"Hypoglycaemia metabolic gene panel testing","volume":"13","author":"Maiorana","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110138_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.70078","article-title":"Loss-of-function CARS1 variants in a patient with microcephaly, developmental delay, and a brittle hair phenotype","volume":"13","author":"Del Greco","year":"2025","journal-title":"Mol. Genet. Genomic Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110138_bb0350","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000538483","article-title":"Idiopathic pathological ketotic hypoglycemia: finding the needle in a haystack","volume":"98","author":"Wolfsdorf","year":"2025","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110138_bb0355","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jimd.12386","article-title":"A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: a retrospective, single-center study and the generation of www.emergencyprotocol.net","volume":"44","author":"Rossi","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110138_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70014","article-title":"Safety and efficacy of DTX401, an AAV8-mediated liver-directed gene therapy, in adults with glycogen storage disease type I a (GSDIa)","volume":"48","author":"Weinstein","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110138_bb0365","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jimd.12640","article-title":"Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: final results of an open-label, long-term extension study","volume":"46","author":"Vockley","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110138_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108144","article-title":"Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: consensus from an international workshop","volume":"141","author":"Gr\u00fcnert","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110138_bb0375","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jimd.12752","article-title":"Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozin","volume":"47","author":"Overduin","year":"2024","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922600421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922600421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:24:14Z","timestamp":1794558254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922600421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S109671922600421X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110138","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biochemical footprints of inherited metabolic disorders: XIX. Hypoglycemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110138"}}